Dana Khdr Sabir¹*, Karzan R Sidiq^1,2, Pyman M Mohamedsalih¹ and Nabaz R Khwarahm³

¹Department of Medical Laboratory Sciences,College of Medicals and Applied Sciences, Charmo University,46023 Chamchamal, Kurdistan Region, Iraq
²Department of Medical Laboratory Science, College of Science, Komar University of Science and Technology, Sulaymani 46002, Kurdistan Region, Iraq
³Department of Biology, College of Education, University of Sulaimani, Sulaimani, Kurdistan Region, Iraq

*Corresponding Author: Dana Khdr Sabir, Department of Medical Laboratory Sciences, Charmo University, Sulaimani, Kurdistan Region, Iraq.

Received: January 12, 2022; Published: February 18, 2022

Abstract

Multidrug resistant (MDR) bacteria are one of the major concerns of the healthcare system in the twenty-first century. Silver nanoparticles (Ag-NPs) have a great potential to be used as new antimicrobials agents to overcome this global issue. In this study, Ag-NPs were biologically synthesized using the aqueous extract of myrtus (Myrtus communis) leaves as a reducing agent. The biosynthesized of Ag-NPs were firstly characterized using UV-visible spectroscopy, X-ray diffractometry (XRD), and Scanning Electron Microscopy (SEM). The absorbance maximum of Ag-NPs was found at 410 nm, and the particles have spherical and/or irregular shapes with an average size of 19 ± 3 nm. The antibacterial activity of the Ag-NPs was then tested against a clinical strain of Acinetobacter baumannii, isolated from a hospitalized burnt patient in the city of Sulaimani-Iraq. Interestingly, the synthesized Ag-NPs were able to inhibit the growth of isolate at the concentration of 0.2 mg/ml. The results of this study suggest a potential antimicrobial activity of biologically synthesized Ag-NPs against MDR bacteria.

Keywords:Acinetobacter baumannii; Silver Nanoparticles; Antibiotic Resistance; Nosocomial Infections

References

1. Altun HU., et al. “Antimicrobial susceptibilities of clinical Acinetobacter baumannii isolates with different genotypes”. Jundishapur Journal of Microbiology12 (2014).
2. Centers for Disease Control and Prevention, Antibiotic resistance threats in the United States 2013. 2013: Centres for Disease Control and Prevention, US Department of Health and Human Services (2013).
3. Madadi-Goli N., et al. “Sensitivity of levofloxacin in combination with ampicillin-sulbactam and tigecycline against multidrug-resistant Acinetobacter baumannii”. Iran Journal of Microbiology1 (2017): 19.
4. Sabir DK. “Synergistic effect of silver nanoparticles combined with different antibiotics against multidrug-resistant Acinetobacter baumannii strain H72721”. in ICNS Conference Proceeding (2018).
5. Sato Y., et al. “Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation”. PloS One3 (2018): e0194556.
6. World Health Organization, Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics, in Geneva: World Health Organization (2017).
7. Manchanda V., et al. “Multidrug resistant Acinetobacter”. Journal of Global Infectious Diseases 3 (2010): 291-304.
8. Sabir DK and KR Sidiq. “Antimicrobial Activity of Combined Cinnamon Nanoemulsions-Antibiotics against Acinetobacter baumannii”. Passer Journal of Basic and Applied Sciences (2019): 1-4.
9. Al-Bdery., et al. “Vancomycin and linezolid resistance among multidrug-resistant Staphylococcus aureus clinical isolates and interaction with neutrophils”. Gene Reports 21 (2020): 100804.
10. Al-Sa'ady., et al. “Genetic relation and virulence factors of carbapenemase-producing Uropathogenic Escherichia coli from urinary tract infections in Iraq”. Gene Reports 21 (2020): 100911.
11. Hiraki Y., et al. “Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy”. International Journal of Infectious Diseases 12 (2013): e1234-1246.
12. Tunyapanit W., et al. “Antimicrobial susceptibility of Acinetobacter baumannii isolated from hospital patients”. Science Asia 40 (2014): 28-34.
13. Harding CM., et al. “Uncovering the mechanisms of Acinetobacter baumannii virulence”. Nature Reviews Microbiology 2 (2018): 91.
14. Lee CR., et al. “Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options”. Frontiers in Cellular and Infection Microbiology 7 (2017): 55.
15. Baptista P., et al. “Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”. Frontiers in Microbiology 9 (2018).
16. Kumar A., et al. “Synthesis, characterization and antibacterial potential of silver nanoparticles by Morus nigra leaf extract”. Indian Journal of Pharmaceutical and Biological Research 1 (2013): 16-24.
17. Singh R., et al. “The role of nanotechnology in combating multi-drug resistant bacteria”. Journal of Nanoscience and Nanotechnology 7 (2014): 4745-4756.
18. Behravan M., et al. “Facile green synthesis of silver nanoparticles using Berberis vulgaris leaf and root aqueous extract and its antibacterial activity”. International Journal of Biological Macromolecules 124 (2019): 148-154.
19. Moodley JS., et al. “Green synthesis of silver nanoparticles from Moringa oleifera leaf extracts and its antimicrobial potential”. Advances in Natural Sciences: Nanoscience and Nanotechnology1 (2018): 015011.
20. Kumar A., et al. “Synthesis, characterization and antibacterial potential of silver nanoparticles by Morus nigra leaf extract”. Indian Journal of Pharmaceutical and Biological Research 4 (2013): 16-24.
21. Baptista PV., et al. “Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans". Frontiers in Microbiology 9 (2018): 1441.
22. Mohamedsalih PM and DK Sabir. “Biosynthesis of silver nanoparticles using the aqueous extract of chamomile flower and their antibacterial activity against Acinetobacter spp”. Health Biotechnology and Biopharma4 (2020): 48-62.
23. Satokari RM., et al. “Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis”. Applied and Environmental Microbiology 2 (2001): 504-513.
24. Sabir DK., et al. “Investigating differences in the ability of XplA/B-containing bacteria to degrade the explosive hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)”. FEMS Microbiology Letter14 (2017).
25. Turton JF., et al. “Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict”. Journal of Clinical Microbiology 6 (2006): 2630-2634.
26. Cerqueira GM and AY Peleg. “Insights into Acinetobacter baumannii pathogenicity”. IUBMB Life12 (2011): 1055-1060.
27. Mulvaney P. “Surface Plasmon Spectroscopy of Nanosized Metal Particles”. Langmuir 3 (1996): 788-800.
28. Patel JB., et al. “Performance standards for antimicrobial susceptibility testing: twenty-fifth informational supplement” (2015).
29. Mohamedsalih PM and DK Sabir. “Antimicrobial activity of silver nanoparticles with antibiotics against clinically isolated Acinetobacter baumannii”. Passer Journal (2020): 51-56.
30. Ismail A. “Antimicrobial Activity of Silver Nanoparticles Synthesized by Myrtus Communis Extract”. (2013).
31. Das B., et al. “Green synthesized silver nanoparticles destroy multidrug resistant bacteria via reactive oxygen species mediated membrane damage”. Arabian Journal of Chemistry6 (2017): 862-876.
32. Shahat AS and NH Assar. “Biochemical and antimicrobial studies of biosynthesized silver nanoparticles using aqueous extract of Myrtus communis L”. Annals of Biological Research 11 (2015): 90-10.
33. Maiti S., et al. “Antimicrobial activities of silver nanoparticles synthesized from Lycopersicon esculentum extract”. Journal of Analytical Science and Technology1 (2014): 40.
34. Hamouda RA., et al. “Synthesis and biological characterization of silver nanoparticles derived from the cyanobacterium Oscillatoria limnetica”. Scientific Reports1 (2019): 1-17.
35. Moores A and F Goettmann. “The plasmon band in noble metal nanoparticles: an introduction to theory and applications”. New Journal of Chemistry8 (2006): 1121-1132.
36. Qais FA., et al. “Antibacterial Effect of Silver Nanoparticles Synthesized Using Murraya koenigii (L) against Multidrug-Resistant Pathogens”. Bioinorganic Chemistry and Applications 2019 (2019): 11.
37. Pal S., et al. “Does the Antibacterial Activity of Silver Nanoparticles Depend on the Shape of the Nanoparticle? A Study of the Gram-Negative Bacterium Escherichia coli”. Applied and Environmental Microbiology 6 (2007): 1712-1720.
38. Panáček A., et al. “Silver Colloid Nanoparticles:  Synthesis, Characterization, and Their Antibacterial Activity”. The Journal of Physical Chemistry B33 (2006): 16248-16253.
39. Morones JR., et al. “The bactericidal effect of silver nanoparticles”. Nanotechnology10 (2005): 2346-2353.
40. Gao M., et al. “Controlled synthesis of Ag nanoparticles with different morphologies and their antibacterial properties”. Materials Science and Engineering: C1 (2013): 397-404.
41. . “Therapeutic exercise foundation and techniques”. 5^th edition (2007).

Citation

Citation: Dana Khdr Sabir., et al. “Biosynthesized of Silver Nanoparticles from Myrtus communis Leaves and Investigates of their Antimicrobial Activities Against a Clinical Isolate of Acinetobacter baumannii ”. Acta Scientific Microbiology 5.3 (2022): 52-59.

Copyright

Copyright: © 2022 Dana Khdr Sabir., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.